China Fill Finish

China’s Regulatory Mosaic: The Troops Have Their Marching Orders

China’s State Council has announced to its people and to the world that the second largest drug market will become a world leader in pharmaceutical innovation, commercialization and manufacturing. Simply put, China will no longer rely on research-based…


Update on CFDA’s Fast-Track Approval: 7 MNC Products Move to Data Inspection Stage

It’s been a little more than a year since China’s FDA (CFDA) announced sweeping policy changes intended to streamline the review of innovative new drugs and rid their system of subpar applicants blocking the progress of true candidates…


China’s Pharmaceutical “Sea Turtles” – Innovation or Imitation and Does It Matter?

During a discussion about the future direction of immuno-oncology pharmaceuticals at the Annual ChinaBio® Partnering Meeting held in Suzhou, China, last May, one point of disagreement among the panelists was whether the number of Chinese companies targeting development…